Is Biostar Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Biostar Pharmaceuticals Inc (BSPM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biostar Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biostar Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Biostar Pharmaceuticals Inc?

Muslim investors may consider investing in Biostar Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biostar Pharmaceuticals Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Biostar Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biostar Pharmaceuticals Inc updated?

The Shariah compliance status of Biostar Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biostar Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biostar Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Biostar Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Biostar Pharmaceuticals Inc. Stock Analysis BSPM

United States Health Care Nano Cap

BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The firm offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The firm's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The firm's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.

Key Statistics of Biostar Pharmaceuticals Inc (BSPM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

2100.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.05

Market Cap

2.60

Avg. Volume